Alto Ingredients Inc
5 nominees · 3 ballot items.
Election of five directors; advisory “say-on-pay” vote to approve executive compensation; approval of the 2026 Omnibus Incentive Plan; ratification of RSM US LLP as independent registered public accounting firm.
Follow how the vote landed and what changed on Alto Ingredients Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.
On the ballot3
- 1
Election of Directors
ManagementBoard: FORElect five nominees—Gilbert E. Nathan, Bryon T. McGregor, Dianne S. Nury, Maria G. Gray and Alan R. Tank—to the Board of Directors to serve until the next annual meeting or until successors are elected and qualified.
- 2
Advisory Vote on Executive Compensation (Say-on-Pay
ManagementBoard: FORNon-binding advisory resolution to approve the compensation paid to named executive officers as disclosed in the proxy statement.
More detail
This is a non-binding, advisory 'say-on-pay' proposal asking stockholders to approve the overall compensation of the company’s named executive officers as disclosed in the proxy materials. Management seeks this annual advisory endorsement to confirm alignment between executive pay and company performance and to obtain stockholder feedback; the board recommends a FOR vote, citing the company's pay-for-performance philosophy, the mix of base salary, annual incentives and long-term equity awards, and the Compensation Committee’s processes (including use of performance metrics such as Adjusted EBITDA and KPIs). While advisory and not binding, the Compensation Committee will consider the vote results when setting future compensation. The context includes recent links of pay to performance through performance-based equity awards and an annual cash incentive plan tied to Adjusted EBITDA, KPIs, and individual goals; the company also highlights adjustments made to incentive design following investor feedback. The board recommends approval because it believes the programs attract and retain executives, align management’s interests with stockholders, and appropriately incentivize both short- and long-term value creation.
- 3
Approval of 2026 Omnibus Incentive Plan
ManagementBoard: FORApprove the Alto Ingredients, Inc. 2026 Omnibus Incentive Plan, authorizing issuance of up to 7,000,000 shares for awards to officers, employees, non-employee directors, consultants and advisors, replacing the 2016 plan.
More detail
Management seeks shareholder approval of the 2026 Omnibus Incentive Plan to reestablish a stock-based incentive vehicle following termination of the Prior Plan, authorizing up to 7,000,000 shares (approximately 9% of fully diluted shares as of April 28, 2026). The plan is intended to attract, retain and motivate officers, employees, directors and consultants and to align their interests with stockholders through equity ownership and performance-linked awards. Key governance protections include a 10-year maximum term for options and SARs, prohibition on repricing without shareholder approval, no automatic single-trigger acceleration for change in control (except for non-employee directors), clawback provisions, no dividends on unearned awards, no automatic evergreen share increases, limited share recycling, and minimum vesting requirements with narrowly tailored exceptions. The Compensation Committee will administer the plan and may grant various award types (options, SARs, restricted stock, RSUs, performance awards). Shareholder approval is required under Nasdaq rules for equity plans; failure to approve would leave the company without a stockholder-approved plan for new awards (outstanding Prior Plan awards would remain). The Board recommends FOR because it believes the plan supports competitive compensation, retention, and tax-qualified grant ability while incorporating safeguards to protect shareholders.”},{
Nominees on the ballot5
Top institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | VANGUARD CAPITAL MANAGEMENT LLC | 4.1% | 3,180,211 | $15M |
| 2 | MARSHALL WACE, LLP | 3.0% | 2,361,744 | $11M |
| 3 | TWO SIGMA INVESTMENTS, LP | 2.6% | 2,006,760 | $10M |
| 4 | MILLENNIUM MANAGEMENT LLC | 2.5% | 1,915,990 | $9M |
| 5 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 2.3% | 1,790,263 | $9M |
| 6 | RENAISSANCE TECHNOLOGIES LLC | 2.2% | 1,673,657 | $8M |
| 7 | BlackRock, Inc. | 1.4% | 1,110,517 | $5M |
| 8 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 1.4% | 1,085,835 | $5M |
| 9 | Hillsdale Investment Management Inc. | 1.3% | 1,000,703 | $5M |
| 10 | Qube Research Technologies Ltd | 1.3% | 969,959 | $5M |
Other Basic Materials sector meetings6
Upcoming shareholder meetings at Alto Ingredients Inc’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Frequently asked questions
- When is the Alto Ingredients Inc 2026 annual meeting?
- Alto Ingredients Inc (ALTO) holds its 2026 annual shareholder meeting on Tuesday, June 23, 2026.
- What is the record date for the Alto Ingredients Inc 2026 meeting?
- The record date for the Alto Ingredients Inc 2026 meeting is Tuesday, April 28, 2026. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for Alto Ingredients Inc's 2026 meeting?
- The board is presenting 5 director nominees at the Alto Ingredients Inc 2026 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the Alto Ingredients Inc 2026 meeting?
- Shareholders will vote on 3 proposals at the Alto Ingredients Inc 2026 meeting, each tagged with who proposed it and the board's recommendation.
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.